Abstract
BACKGROUND: Dermatophytosis is a world-wide distributed common infection. Antifungal drug resistance in dermatophytosis used to be rare, but unfortunately the current Indian epidemic of atypical widespread recalcitrant and terbinafine-resistant dermatophytosis is spreading and has sporadically been reported in Europe.
OBJECTIVES: To explore the occurrence of clinical and mycological proven antifungal drug resistance in dermatophytes in Europe.
METHODS: A standardized questionnaire was distributed through the EADV Task Force of Mycology network to dermatologists in Europe.
RESULTS: Representatives from 20 countries completed the questionnaires of which 17 (85 %) had observed clinical and/or mycological confirmed antifungal resistance, two countries published cases of antifungal resistance and one country had no known cases.
CONCLUSIONS: This pilot study confirms that both clinical and mycological antifungal resistance exist in Europe.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Journal of the European Academy of Dermatology and Venereology : JEADV |
| Vol/bind | 35 |
| Udgave nummer | 7 |
| Sider (fra-til) | 1582-1586 |
| Antal sider | 5 |
| ISSN | 0926-9959 |
| DOI | |
| Status | Udgivet - jul. 2021 |
| Udgivet eksternt | Ja |